Triple therapy with non-biologic DMARDs for rheumatoid arthritis or biologic therapy. Is it the same?

Predictors of response to biologic therapies in rheumatoid arthritis Lara M. Chaves Chaparro, Juan Salvatierra Ossorio, Enrique Raya Álvarez

Glucocorticoids for rheumatoid arthritis in the era of targeted therapies Maarten Boers